BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng WJ, Yao M, Fang M, Wang L, Dong ZZ, Yao DF. Abnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytes. World J Gastroenterol 2018; 24(32): 3650-3662 [PMID: 30166860 DOI: 10.3748/wjg.v24.i32.3650] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Sharma P, Yadav P, Sundaram S, Venkatraman G, Bera AK, Karunagaran D. HMGB3 inhibition by miR-142-3p/sh-RNA modulates autophagy and induces apoptosis via ROS accumulation and mitochondrial dysfunction and reduces the tumorigenic potential of human breast cancer cells. Life Sci 2022;:120727. [PMID: 35753437 DOI: 10.1016/j.lfs.2022.120727] [Reference Citation Analysis]
2 Wen B, Wei YT, Zhao K. The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance. Mol Cell Biochem 2021;476:1729-39. [PMID: 33428061 DOI: 10.1007/s11010-020-04015-y] [Reference Citation Analysis]
3 Poluan RH, Sudigyo D, Rahmawati G, Setiasari DW, Sesotyosari SL, Wardana T, Astuti I, Heriyanto DS, Indrasari SR, Herawati C, Afiahayati -, Haryana SM. Transcriptome Related to Avoiding Immune Destruction in Nasopharyngeal Cancer in Indonesian Patients Using Next-Generation Sequencing. Asian Pac J Cancer Prev 2020;21:2593-601. [PMID: 32986357 DOI: 10.31557/APJCP.2020.21.9.2593] [Reference Citation Analysis]
4 Gu J, Xu T, Huang QH, Zhang CM, Chen HY. HMGB3 silence inhibits breast cancer cell proliferation and tumor growth by interacting with hypoxia-inducible factor 1α. Cancer Manag Res 2019;11:5075-89. [PMID: 31213919 DOI: 10.2147/CMAR.S204357] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
5 Zheng W, Yang J, Dong Z, Wang L, Fang M, Wu W, Yao D, Yao M. High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma. Cancer Manag Res. 2018;10:5979-5989. [PMID: 30538547 DOI: 10.2147/cmar.s181742] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]